Skip to main content
. 2022 Sep 27;6(22):5857–5865. doi: 10.1182/bloodadvances.2022008632

Figure 3.

Figure 3.

Survival, relapse, and non-relapse mortality. (A) OS, PFS, and GRFS. (B) Cumulative incidence of relapse and NRM.